FDA Cleared Is Not FDA Approved: What Clinics Need to Know

Aesthetic-device manufacturers and clinics routinely use "FDA approved" in marketing for devices the FDA has cleared — not approved. The two words describe different regulatory pathways with different evidence requirements, legal meanings and marketing boundaries.

This article is for clinic owners, medical directors and purchasing decision-makers who evaluate aesthetic devices — lasers, IPL systems, microneedling devices, radiofrequency platforms, ultrasound units and energy-based devices generally. It explains the distinction between a 510(k) clearance and a Premarket Approval (PMA), what each requires from the manufacturer and what each allows you to say.

The short answer — United States, evidence checked July 16, 2026: "FDA cleared" means the manufacturer showed the device is substantially equivalent to a device already legally marketed. "FDA approved" means the manufacturer submitted clinical data demonstrating safety and effectiveness through the PMA pathway. These are not the same thing. Calling a cleared device "approved" is inaccurate and can draw regulatory attention from the FDA and the FTC.

Why the distinction matters for clinics

The Federal Food, Drug, and Cosmetic Act gives the FDA authority over medical devices based on risk. A device's class — I, II or III — determines what the manufacturer must do before marketing it. Clinic owners who buy or lease aesthetic devices inherit the legal obligations attached to those marketing claims. If you say a 510(k)-cleared device is "FDA approved," that claim is false.

The FDA's own consumer-facing explainer on clearance versus approval, content current as reviewed July 2024, states directly: "FDA review of medical devices differs based on the class to which a device belongs." It defines clearance as one outcome and approval as a different, more rigorous one.

From a regulatory-compliance standpoint, the word you use — cleared versus approved — is a representation about the evidence the manufacturer submitted. It is not a branding choice.

Device classification: I, II and III

The FDA classifies over 1,700 distinct types of medical devices into three risk-based categories, described in the agency's device-classification guidance. Class determines the regulatory pathway a manufacturer must follow.

Class I devices present the lowest risk. Examples include tongue depressors, examination gloves and manual stethoscopes. Most Class I devices are exempt from premarket notification. Few have any relevance to aesthetics.

Class II devices represent moderate risk and cover the majority of aesthetic energy-based devices: most laser systems, intense pulsed light (IPL) platforms, radiofrequency devices and microneedling units. These devices typically enter the market through the 510(k) premarket notification pathway. The manufacturer must demonstrate that the device is substantially equivalent to a predicate device already legally on the market.

Class III devices sustain or support human life, are of substantial importance in preventing impairment of health, or present a potential unreasonable risk of illness or injury. Examples include implantable pacemakers, breast implants and certain high-risk aesthetic implants or energy devices for which no valid predicate exists. These devices require Premarket Approval (PMA) — the most stringent scientific and regulatory review the FDA applies to medical devices.

The FDA's searchable Product Classification Database allows anyone to look up a specific device type and see its class, regulation number and review pathway. Clinic owners can use this database to check the class of any device they are considering before relying on a manufacturer's marketing description.

What 510(k) clearance actually means

The 510(k) premarket notification pathway, named after section 510(k) of the Food, Drug, and Cosmetic Act, is defined in the agency's 510(k) program guidance. It requires the manufacturer to submit data showing that the device is substantially equivalent to a predicate device — a legally marketed device that was not subject to PMA.

Key facts about 510(k) clearance:

• The manufacturer does not need to submit clinical data proving the device is safe and effective on its own. Instead, the manufacturer relies on the predicate's safety record.
• Substantial equivalence means the device has the same intended use and the same technological characteristics as the predicate, or different technological characteristics that do not raise new safety or effectiveness questions.
• The FDA issues a "clearance letter" — not an approval. The device is cleared for marketing.
• More than 4,000 510(k) submissions are reviewed annually, covering the great majority of aesthetic energy-based devices.

Definition → governing distinction → mechanism: A 510(k) clearance says the new device resembles a previously marketed device closely enough that the FDA does not require the manufacturer to independently prove safety and effectiveness through clinical trials. Clearance relies on equivalence. Approval relies on original evidence.

The limitation of clearance is structural: if the predicate device has never been tested in a controlled clinical trial for the aesthetic claim being marketed, the cleared device inherits that evidence gap. A clearance letter does not certify that the device works for a specific outcome — it certifies equivalence to a legally marketed reference.

What PMA approval requires

Premarket Approval (PMA) is the FDA's most stringent device-review process. The FDA's PMA program description states that a PMA application must contain "valid scientific evidence" that the device is safe and effective for its intended use.

A PMA submission typically includes:

• Controlled clinical trial data
• Nonclinical laboratory studies
• Manufacturing and quality-system documentation
• Detailed device descriptions and specifications
• Labeling and proposed claims

Where a 510(k) pathway can take a few months, the PMA review can take a year or longer. The FDA may require an advisory panel of outside experts to review the clinical data and make a recommendation before the agency reaches a decision. When the FDA grants a PMA, it issues an approval letter. The device is "FDA approved."

Few aesthetic devices go through the PMA pathway because most can rely on a predicate under 510(k). Devices that cannot find a valid predicate — or that are automatically classified as Class III because of their risk profile — must pursue PMA or, for certain novel low- to moderate-risk devices, the De Novo classification pathway, which creates a new Class II classification.

Common examples in aesthetic medicine

Most aesthetic lasers and energy-based devices marketed in the United States enter through 510(k) clearance. Examples include:

• Fractional CO₂ laser systems for skin resurfacing
• HIFU platforms for noninvasive skin tightening
• Cryolipolysis devices for fat reduction
• Radiofrequency microneedling units
• Broadband light (BBL) and IPL platforms

A 510(k)-cleared device may be promoted for the same intended use as its predicate — but the manufacturer is responsible for ensuring that claims are supported by evidence, even if the evidence was not part of the 510(k) submission. A clearance letter alone does not prove that a device achieves a particular cosmetic outcome, and the FTC separately requires that advertising claims be truthful and evidence-based.

The FDA maintains a public list of medical device databases that allows clinics to verify a specific device's 510(k) number, clearance date, classification and predicate device. Any clinic evaluating a device should check this database before accepting a manufacturer's marketing language.

What happens when a clinic says "FDA approved" for a cleared device

Using "FDA approved" for a 510(k)-cleared device is an inaccurate marketing claim. The FDA's own consumer page draws the distinction explicitly: the word "approved" is reserved for devices that have gone through the PMA pathway or, in the drug context, the New Drug Application process.

Clinics that adopt a manufacturer's misleading language may face:

• FDA enforcement: The agency can issue warning letters for misbranding if a device is promoted using claims that exceed what the clearance or approval covers.
• FTC scrutiny: The FTC's advertising and marketing guidance requires claims to be truthful, not deceptive and evidence-based. Calling a cleared device "FDA approved" is deceptive.
• Civil liability risk: Patients who rely on "FDA approved" representations may have a basis for misrepresentation or fraud claims if the device's actual regulatory status is less demanding — and especially if the device causes an adverse outcome.

A clinic cannot fix this problem by adding a disclaimer elsewhere. The disclaimer cannot repair inaccurate copy, as the MedspaGuide style card notes. The primary claim — "FDA approved" — must be accurate at the point of use.

The De Novo alternative

Some novel moderate-risk devices that lack a valid predicate cannot use 510(k) and do not warrant Class III PMA. The De Novo classification pathway allows manufacturers to request classification into Class I or II, creating a new predicate for future 510(k) submissions.

De Novo devices receive a "classification order" — not clearance and not approval. The agency uses the term "granted" or "classified." Calling a De Novo device "FDA approved" or "FDA cleared" with the same weight as a 510(k) is also inaccurate unless the specific context is precise.

What clinics should do

1. Check the device's actual regulatory pathway. Use the FDA's Product Classification Database and the Medical Device Databases to find the 510(k) number or PMA number for any device you are evaluating.
2. Audit your marketing claims. Review your website, social media, consent forms and brochures for "FDA approved" references. Replace them with "FDA cleared" where the record shows 510(k) clearance, or "FDA classified" for De Novo devices.
3. Request the 510(k) summary from the manufacturer. Manufacturers are required to make a 510(k) summary available upon request. Read it. Understand what the predicate does and does not prove.
4. Ask what evidence supports the specific outcome claim. A 510(k) clearance for "wrinkle reduction" does not mean the manufacturer submitted wrinkle-reduction efficacy data. Ask for the clinical evidence behind the specific claim you intend to make.
5. Train your staff. Front-desk staff, consultants and treatment coordinators should know the difference between cleared and approved and should use accurate language when describing devices to patients.

What this article does not cover

This article does not analyze any specific device, manufacturer or clinic. It does not compare the clinical outcomes of 510(k)-cleared versus PMA-approved devices — clinical effectiveness depends on the specific device, technique and patient population, not the regulatory pathway alone. It does not review the international regulatory frameworks that apply to devices marketed outside the United States.

The classification system described here is general. Some Class II devices may require clinical data through special controls. Some Class III devices may be exempt from PMA if a valid predicate exists. Consult the specific device record and FDA guidance for the exact regulatory history of any device.

The bottom line

Aesthetic devices enter the US market through different regulatory pathways that correspond to their risk class. Most energy-based devices enter through 510(k) clearance, which requires a showing of substantial equivalence — not independent clinical evidence of safety and effectiveness.

PMA approval is a higher evidentiary standard reserved for high-risk devices. The word "approved" carries that meaning.

Clinics that correctly use "FDA cleared" instead of "FDA approved" are making a legally and factually accurate representation. Clinics that use "FDA approved" for a cleared device are making a false claim — and the manufacturer's marketing materials are not a defense.